Shanghai ZJ Bio-Tech Co

Shanghai ZJ Bio-Tech Co ROE

The Return on Equity (ROE) of Shanghai ZJ Bio-Tech Co (688317.SS) as of Oct 31, 2026 is -1.02 %. In the previous year, Return on Equity (ROE) was -3.50 % — a change of -70.77% (higher).

ROE

-1.02 %

YoY

-70.77%

Last updated:

In 2025, Shanghai ZJ Bio-Tech Co's return on equity (ROE) was -1.02 %, a -70.77% increase from the -3.50 % ROE in the previous year.

The Shanghai ZJ Bio-Tech Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
11.70 CNY
Jan 1, 2019
9.01 CNY
Jan 1, 2020
63.72 CNY
Jan 1, 2021
19.82 CNY
Jan 1, 2022
18.10 CNY
Jan 1, 2023
-3.58 CNY
Jan 1, 2024
-3.50 CNY
Jan 1, 2025
-1.02 CNY
The Shanghai ZJ Bio-Tech Co ROE history
YEARROEYoY
-1.02 %-70.77%
-3.50 %-2.05%
-3.58 %-119.77%
18.10 %-8.67%
19.82 %-68.90%
63.72 %+607.26%
9.01 %-22.99%
11.70 %+7.31%
10.90 %+8.21%
10.07 %+6.34%
9.47 %-70.16%
31.75 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai ZJ Bio-Tech Co Stock analysis

What does Shanghai ZJ Bio-Tech Co do? Shanghai ZJ Bio-Tech Co., Ltd. generates revenue through the research, development, production, and sale of molecular diagnostic reagents and instruments. The company's primary products are nucleic acid detection kits and molecular diagnostic instruments, which are sold to customers in sectors including emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The firm focuses its business activities within the domestic market, targeting institutions and organizations requiring diagnostic solutions for public health and clinical applications. The company's business model centers on providing diagnostic reagents and equipment for critical applications such as emergency public health safety and medical clinical diagnosis. Its products are designed to meet the needs of domestic customers in healthcare, public safety, and food safety sectors, with a strong emphasis on molecular diagnostics. Shanghai ZJ Bio-Tech leverages its domestic market presence to serve institutions requiring reliable diagnostic tools for health and safety monitoring. Shanghai ZJ Bio-Tech Co., Ltd. operates with a domestic market focus, selling its molecular diagnostic instruments and reagents to entities involved in public health, clinical diagnosis, and food safety. The firm's revenue streams are derived from the sale of nucleic acid detection kits and molecular diagnostic instruments, which are essential for applications in emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. Shanghai ZJ Bio-Tech Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Shanghai ZJ Bio-Tech Co's Return on Equity (ROE)

Shanghai ZJ Bio-Tech Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Shanghai ZJ Bio-Tech Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Shanghai ZJ Bio-Tech Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Shanghai ZJ Bio-Tech Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Shanghai ZJ Bio-Tech Co stock

Return on Equity (ROE) of Shanghai ZJ Bio-Tech Co is -1.02 % in 2025.

Return on Equity (ROE) of Shanghai ZJ Bio-Tech Co changed from -3.50 % to -1.02 %, representing a -70.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Shanghai ZJ Bio-Tech Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Shanghai ZJ Bio-Tech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Shanghai ZJ Bio-Tech Co

All Key Metrics — Shanghai ZJ Bio-Tech Co